Table 2.
Distribution of Charlson Comorbidities and Mortality in Patient Cohort (n = 58,771).
| Charlson Comorbidities | Comorbidity | Mortality | ||
|---|---|---|---|---|
| n | % | n | % | |
| Myocardial infarction | 48 | 0.1 | 31 | 64.6 |
| Congestive heart failure | 187 | 0.3 | 117 | 62.6 |
| Peripheral vascular disease | 76 | 0.1 | 33 | 43.4 |
| Cerebrovascular disease | 832 | 1.4 | 368 | 44.2 |
| Dementia | 540 | 0.9 | 284 | 52.6 |
| Chronic pulmonary disease | 1865 | 3.2 | 574 | 30.8 |
| Rheumatic disease | 773 | 1.3 | 205 | 26.5 |
| Peptic ulcer disease | 2443 | 4.2 | 616 | 25.2 |
| Mild liver disease | 1379 | 2.3 | 407 | 29.5 |
| Diabetes mellitus without end-organ damage | 1956 | 3.3 | 744 | 38.0 |
| Diabetes mellitus with end-organ damage | 228 | 0.4 | 115 | 50.4 |
| Hemiplegia | 84 | 0.1 | 36 | 42.9 |
| Renal disease | 339 | 0.6 | 157 | 46.3 |
| Any malignancy, including lymphoma and leukemia, except malignant neoplasm of skin | 277 | 0.5 | 129 | 46.6 |
| Moderate liver disease | 75 | 0.1 | 54 | 72.0 |
| Metastatic solid tumor | 31 | 0.1 | 23 | 74.2 |
| HIV/AIDS | - | - | - | - |
AIDS = acquired immunodeficiency syndrome, HIV = human immunodeficiency virus.